# Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

> **NCT03208868** · NA · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 32 (estimated)

## Conditions studied

- Cirrhosis, Liver

## Interventions

- **DIETARY_SUPPLEMENT:** Leucine enriched essential amino acid (EEA/LEU)
- **DIETARY_SUPPLEMENT:** Balanced amino acid supplement (BAA)

## Key facts

- **NCT ID:** NCT03208868
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-08-05
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03208868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03208868, "Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03208868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*